|
PEPTRON is a biotechnology company specializing in the design, development, and manufacturing of long-acting peptide therapeutics and antibody-based drugs. The company utilizes its proprietary SmartDepot technology, an ultrasonic spray-drying platform, to create sustained-release formulations that extend the half-life of active ingredients. Its business segments include the development of new drugs, the provision of custom peptide synthesis services for research and clinical trials, and contract development and manufacturing (CDMO) for pharmaceutical partners. Key pipeline products include PT320 for Parkinson's disease, PT105 for prostate cancer, PT403 for diabetes and obesity, and PAb001, an antibody-drug conjugate candidate targeting MUC1. PEPTRON also markets a pharmaceutical product containing hyaluronidase for the early suppression of edema in post-cesarean section patients. The company serves research institutions, pharmaceutical companies, and hospitals, with a focus on global markets through strategic licensing partnerships. Founded in 1997, PEPTRON operates a GMP-compliant manufacturing facility to support clinical trials and commercial production. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Biotechnology | Homepage peptron.co.kr |
| Sector Healthcare | IR page peptron.co.kr | |
|
Tags
peptide therapeutics, long-acting drugs, drug delivery systems, antibody-drug conjugates, cdmo, custom peptide synthesis, neurology, oncology, endocrinology, gynecology, SmartDepot, PepGen, PT320, PT105, PT403, PAb001, PND3174, COZYCURE
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | ₩ 2.468T |
| Market cap (USD) | $ 1.817B |
| P/E | -119.99 |
| PEG | — |
| P/BV | 19.06 |
| P/S | 411.33 |
| P/OCF | -121.86 |
| P/FCF | -83.63 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -9.4% |
| ROI | -9.7% |
| ROIC | -11.2% |
| Profit margin | -245.3% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | Yes |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | — |
| Quality score | -41.2% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.635B | 3.152B | 3.342B | 5.814B | 6.625B | 3.121B | 1.801B | 3.862B | 3.215B | 3.131B | 2.812B | 2.484B | 3.103B |
| Net profit | -13.824B | -22.034B | -15.922B | -15.063B | -15.042B | -18.382B | -17.718B | -3.726B | -4.427B | -3.191B | -2.73B | -3.046B | -2.059B |
| Free cash flow | -23.08B | -13.775B | -11.705B | -13.245B | -11.313B | -16.648B | -14.606B | -14.316B | -27.471B | -5.515B | -2.605B | -3.465B | -1.382B |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (KRW) | 274M | 720M | 40.1M | 70.7M | 412M | 387M | 371M | 415M | 331M | 612M |
| ↳ YoY growth | +1,941.0% | +163.0% | -94.4% | +76.4% | +483.1% | -6.0% | -4.3% | +11.8% | -20.1% | +84.6% |
| ↳ 5y CAGR | +23.4% | +62.8% | +98.4% | +7.2% | -12.4% | +59.6% | +36.2% | +8.2% | ||
| Other receivables (KRW) | 274M | 180M | 355M | 868M | 628M | 669M | 1.39B | 860M | 1.48B | 1.4B |
| Borrowings, current (KRW) | 0.00 | — | — | — | — | — | 9.05B | 4.55B | 990M | 3.49B |
| Borrowings, non-current (KRW) | 2B | 2B | — | 3B | 9.05B | 6.05B | — | 4.5B | 8.06B | 5.56B |
| Bonds payable (KRW) | — | 0.00 | — | — | — | — | — | — | — | — |
| Lease liabilities (KRW) | — | — | 0.00 | 41M | 188M | 107M | 177M | 84M | 187M | 472M |
| Cash and deposits (KRW) | 3.54B | 962M | 1.8B | 2.45B | 68B | 4.64B | 5.04B | 4.26B | 1.05B | 4.38B |
| Intangible assets (KRW) | 1.24B | 1.06B | 954M | 902M | 647M | 605M | 675M | 1.81B | 2.84B | 3.18B |
| Net debt (borrowings + leases - cash) (KRW) | -1.54B | 1.04B | — | 591M | -58.7B | 1.52B | 4.19B | 4.87B | 8.19B | 5.14B |
| Cash flow detail | ||||||||||
| Operating cash flow (KRW) | -2.73B | -5.63B | -4.18B | -9.6B | -13.6B | -10.6B | -11.7B | -11B | -12.8B | -20.6B |
| Purchases of property, plant and equipment (KRW) | -2.78B | -21.8B | -10.1B | -5.01B | -3.1B | -699M | -1.52B | -731M | -1.01B | -2.49B |
| Purchases of intangible assets (KRW) | -200M | -28.9M | -47.8M | -99.9M | -73.1M | -76.2M | -191M | -1.26B | -1.16B | -503M |
| Share buybacks (cash effect) (KRW) | — | — | — | — | — | — | — | -891M | 0.00 | 0.00 |
| Interest paid (cash effect) (KRW) | -70.6M | -60.6M | -117M | -126M | -219M | -254M | -273M | -379M | -484M | -324M |
| Income taxes paid (cash effect) (KRW) | -17M | -76.8M | 45.3M | -45.9M | 83.1M | -320M | -42M | 19.7M | 14.4M | -577M |
| Free cash flow (OCF - PPE - intangibles) (KRW) | -5.71B | -27.5B | -14.4B | -14.7B | -16.7B | -11.4B | -13.4B | -13B | -14.9B | -23.6B |
| Income detail | ||||||||||
| Total comprehensive income (KRW) | -3.53B | -4.26B | -3.83B | -17.2B | -18.5B | -15B | -9.27B | -16.1B | -22.1B | -14.6B |
| Reported | Nov 14, 2017 | Jul 31, 2018 | Aug 13, 2021 | Mar 30, 2020 | Aug 13, 2021 | Mar 20, 2024 | Mar 20, 2024 | Mar 20, 2024 | Mar 18, 2026 | Mar 18, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpDisclosures filed with DART (material events and exchange disclosures), newest first, headlines as filed in Korean. The link opens the filing on DART. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding PEPTRON
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| DFAE | 0.01% | 6,523 | $ 475.577K | Nov 12, 2026 |

> 공지 > NEWS